Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederpfizer.com
https://www.pfizer.com/newsfeed
Get the latest updates from https://www.pfizer.com/newsfeed directly as they happen.
Follow now 229 followers
Latest posts
Last updated over 2 years ago
Pfizer to Acquire Biohaven Pharmaceuticals
over 2 years ago
Pfizer to Acquire Biohaven Pharmaceuticals Anonymous (not verified) Tue, 05/10/2022 - 06:45...
Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA) for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis
over 2 years ago
Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA)...
Pfizer Presents Positive Real-World Evidence for First-Line IBRANCE® (palbociclib) Combination Therapy in HR+, HER2- Metastatic Breast Cancer at ESMO Breast Cancer 2022
over 2 years ago
Pfizer Presents Positive Real-World Evidence for First-Line IBRANCE® (palbociclib) Combination Therapy in...
Pfizer Reports First-Quarter 2022 Results
over 2 years ago
Pfizer Reports First-Quarter 2022 Results Anonymous (not verified) Tue, 05/03/2022 - 06:45...
Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing to Develop Next-Generation Non-viral Gene Therapies
over 2 years ago
Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing to Develop Next-Generation...
Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer
over 2 years ago
Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer deliesschef Mon, 05/02/2022...
Pfizer Shares Top-Line Results from Phase 2/3 EPIC-PEP Study of PAXLOVIDTM for Post-Exposure Prophylactic Use
over 2 years ago
Pfizer Shares Top-Line Results from Phase 2/3 EPIC-PEP Study of PAXLOVIDTM for...
Pfizer Announces 2022 Shareholder Meeting Preliminary Results
over 2 years ago
Pfizer Announces 2022 Shareholder Meeting Preliminary Results kimkevin Thu, 04/28/2022 - 15:26...
Pfizer Declares Second-Quarter 2022 Dividend
over 2 years ago
Pfizer Declares Second-Quarter 2022 Dividend Anonymous (not verified) Thu, 04/28/2022 - 08:00...
Pfizer to Open First U.S. Sites in Phase 3 Trial of Investigational Gene Therapy for Ambulatory Patients with Duchenne Muscular Dystrophy
over 2 years ago
Pfizer to Open First U.S. Sites in Phase 3 Trial of Investigational...
Pfizer and Biohaven’s VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine
over 2 years ago
Pfizer and Biohaven’s VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by European...
Pfizer and BioNTech Submit Application for U.S. Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age
over 2 years ago
Pfizer and BioNTech Submit Application for U.S. Emergency Use Authorization for a...